Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children

Paola Marchisio, Roberta Cavagna, Barbara Maspes, Stefania Gironi, Susanna Esposito, Lara Lambertini, Alessandra Massimini, Christian Herzog, Nicola Principi

Research output: Contribution to journalArticle

Abstract

To evaluate the efficacy of an intranasal, inactivated, virosomal subunit influenza vaccine for prevention of new episodes of acute otitis media (AOM) in children with recurrent AOM, 133 children aged 1-5 years were randomized to receive the vaccine (n = 67) or no vaccination (n = 66). During a 6-month period, 24 (35.8%) vaccine recipients had 32 episodes of AOM; 42 (63.6%) control subjects had 64 episodes. The overall efficacy of vaccination in preventing AOM was 43.7% (95% confidence interval, 18.6-61.1; P = .002). Children vaccinated before influenza season had a significantly better outcome than did those vaccinated after the onset of influenza season. The cumulative duration of middle ear effusion was significantly less in vaccinated children than in control subjects. Data suggest that the intranasal virosomal influenza vaccine might be considered among the options for the prevention of AOM in children

Original languageEnglish
Pages (from-to)168-174
Number of pages7
JournalClinical Infectious Diseases
Volume35
Issue number2
DOIs
Publication statusPublished - Jul 15 2002

Fingerprint

Influenza Vaccines
Otitis Media
Human Influenza
Vaccination
Vaccines
Otitis Media with Effusion
Subunit Vaccines
Confidence Intervals

ASJC Scopus subject areas

  • Immunology

Cite this

Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. / Marchisio, Paola; Cavagna, Roberta; Maspes, Barbara; Gironi, Stefania; Esposito, Susanna; Lambertini, Lara; Massimini, Alessandra; Herzog, Christian; Principi, Nicola.

In: Clinical Infectious Diseases, Vol. 35, No. 2, 15.07.2002, p. 168-174.

Research output: Contribution to journalArticle

Marchisio, P, Cavagna, R, Maspes, B, Gironi, S, Esposito, S, Lambertini, L, Massimini, A, Herzog, C & Principi, N 2002, 'Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children', Clinical Infectious Diseases, vol. 35, no. 2, pp. 168-174. https://doi.org/10.1086/341028
Marchisio, Paola ; Cavagna, Roberta ; Maspes, Barbara ; Gironi, Stefania ; Esposito, Susanna ; Lambertini, Lara ; Massimini, Alessandra ; Herzog, Christian ; Principi, Nicola. / Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. In: Clinical Infectious Diseases. 2002 ; Vol. 35, No. 2. pp. 168-174.
@article{c056fcdfb9f242259edb66b05858bcaf,
title = "Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children",
abstract = "To evaluate the efficacy of an intranasal, inactivated, virosomal subunit influenza vaccine for prevention of new episodes of acute otitis media (AOM) in children with recurrent AOM, 133 children aged 1-5 years were randomized to receive the vaccine (n = 67) or no vaccination (n = 66). During a 6-month period, 24 (35.8{\%}) vaccine recipients had 32 episodes of AOM; 42 (63.6{\%}) control subjects had 64 episodes. The overall efficacy of vaccination in preventing AOM was 43.7{\%} (95{\%} confidence interval, 18.6-61.1; P = .002). Children vaccinated before influenza season had a significantly better outcome than did those vaccinated after the onset of influenza season. The cumulative duration of middle ear effusion was significantly less in vaccinated children than in control subjects. Data suggest that the intranasal virosomal influenza vaccine might be considered among the options for the prevention of AOM in children",
author = "Paola Marchisio and Roberta Cavagna and Barbara Maspes and Stefania Gironi and Susanna Esposito and Lara Lambertini and Alessandra Massimini and Christian Herzog and Nicola Principi",
year = "2002",
month = "7",
day = "15",
doi = "10.1086/341028",
language = "English",
volume = "35",
pages = "168--174",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "NLM (Medline)",
number = "2",

}

TY - JOUR

T1 - Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children

AU - Marchisio, Paola

AU - Cavagna, Roberta

AU - Maspes, Barbara

AU - Gironi, Stefania

AU - Esposito, Susanna

AU - Lambertini, Lara

AU - Massimini, Alessandra

AU - Herzog, Christian

AU - Principi, Nicola

PY - 2002/7/15

Y1 - 2002/7/15

N2 - To evaluate the efficacy of an intranasal, inactivated, virosomal subunit influenza vaccine for prevention of new episodes of acute otitis media (AOM) in children with recurrent AOM, 133 children aged 1-5 years were randomized to receive the vaccine (n = 67) or no vaccination (n = 66). During a 6-month period, 24 (35.8%) vaccine recipients had 32 episodes of AOM; 42 (63.6%) control subjects had 64 episodes. The overall efficacy of vaccination in preventing AOM was 43.7% (95% confidence interval, 18.6-61.1; P = .002). Children vaccinated before influenza season had a significantly better outcome than did those vaccinated after the onset of influenza season. The cumulative duration of middle ear effusion was significantly less in vaccinated children than in control subjects. Data suggest that the intranasal virosomal influenza vaccine might be considered among the options for the prevention of AOM in children

AB - To evaluate the efficacy of an intranasal, inactivated, virosomal subunit influenza vaccine for prevention of new episodes of acute otitis media (AOM) in children with recurrent AOM, 133 children aged 1-5 years were randomized to receive the vaccine (n = 67) or no vaccination (n = 66). During a 6-month period, 24 (35.8%) vaccine recipients had 32 episodes of AOM; 42 (63.6%) control subjects had 64 episodes. The overall efficacy of vaccination in preventing AOM was 43.7% (95% confidence interval, 18.6-61.1; P = .002). Children vaccinated before influenza season had a significantly better outcome than did those vaccinated after the onset of influenza season. The cumulative duration of middle ear effusion was significantly less in vaccinated children than in control subjects. Data suggest that the intranasal virosomal influenza vaccine might be considered among the options for the prevention of AOM in children

UR - http://www.scopus.com/inward/record.url?scp=0037100467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037100467&partnerID=8YFLogxK

U2 - 10.1086/341028

DO - 10.1086/341028

M3 - Article

C2 - 12087523

AN - SCOPUS:0037100467

VL - 35

SP - 168

EP - 174

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 2

ER -